

Anbio Biotechnology reported strong 2025 results with sales of $8.65M. The company is diversifying away from COVID products.
You can purchase shares of Anbio Biotechnology (NASDAQ:NNNN) through any online brokerage.
Other companies in Anbio Biotechnology’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for Anbio Biotechnology to provide a consensus price target.
The stock price for Anbio Biotechnology (NASDAQ: NNNN) is $3.68 last updated November 3, 2026 at 9:20 AM EST.
There are no upcoming dividends for Anbio Biotechnology.
Anbio Biotechnology does not have any upcoming earnings scheduled.
There is no upcoming split for Anbio Biotechnology.
Anbio Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient...